IEFM
CRBP icon

IQ EQ Fund Management’s Corbus Pharmaceuticals CRBP Stock Holding History

IQ EQ Fund Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,240
Closed -$115K – 220
2022
Q2 		$115K Buy
15,240
+730
+5% +$7.05K 0.02% 188
2022
Q1 		$231K Buy
14,510
+3,888
+37% +$51.5K 0.04% 180
2021
Q4 		$196K Buy
10,622
+968
+10% +$26.2K 0.03% 207
2021
Q3 		$295K Sell
9,654
-86,488
-90% -$3.41M 0.05% 227
2021
Q2 		$5.28M Buy
96,142
+24,074
+33% +$1.34M 0.81% 34
2021
Q1 		$4.26M Buy
72,068
+70,170
+3,697% +$4.61M 0.75% 31
2020
Q4 		$71K Buy
1,898
+1,068
+129% +$39.9K 0.02% 226
2020
Q3 		$45K Buy
830
+282
+51% +$51.1K 0.01% 193
2020
Q2 		$138K Buy
548
+181
+49% +$36.6K 0.05% 183
2020
Q1 		$58K Buy
+367
New +$62K 0.02% 137

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IQ EQ Fund Management's CRBP Position: Q3 2022 in Review

IQ EQ Fund Management sold out of Corbus Pharmaceuticals (CRBP) in Q3 2022, closing a stake of 15,240 shares — an estimated $115K sold.

IQ EQ Fund Management first reported a position in CRBP in Q1 2020 and held it in 10 quarters. The position peaked at $5.28M in Q2 2021. 64 funds tracked by Wall St. Rank hold CRBP as of Q3 2022.

  • IQ EQ Fund Management reported no remaining Corbus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • IQ EQ Fund Management sold 15,240 Corbus Pharmaceuticals shares in Q3 2022, an estimated $115K.
  • IQ EQ Fund Management first reported a position in Corbus Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • IQ EQ Fund Management's Corbus Pharmaceuticals position peaked at $5.28M in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2022.

Based on IQ EQ Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.